Clinical Certificate

Anxiety Disorders

Date: Thursday 26th January 2017 – Friday 27th January 2017
Venue: The Bristol Hotel, Prince Street, Bristol, BS1 4QF
Accommodation: The Bristol Hotel, Prince Street, Bristol , BS1 4QF
(accommodation is chargeable separately when you complete the online booking form)
Organised by: David Nutt and John Potokar
Booking Status: FULLY BOOKED

Programme

Thursday 26 January
13:00–13:30 Arrival, registration and light lunch
13:30–13:35 Introduction
Dr John Potokar (Bristol)
13:35–15:00 Evidence-based pharmacological treatment of anxiety disorders
Professor David Baldwin (Southampton)
15:00–15:15 Refreshments
15:15–16:30 Two Groups
Group A: Anxiety in the Medical Setting
Dr John Potokar (Bristol) and Dr Nicola Taylor (Bristol)
Group B: Benzodiazepines in Anxiety Disorders
Dr Fergus Law (Bristol) and Dr Jan Melichar (Bristol)
16:30–16:45 Refreshments and presenters swap rooms
16:45–18:00 Two Groups (repeated)
Group A: Anxiety in the Medical Setting
Dr John Potokar (Bristol) and Dr Nicola Taylor (Bristol)
Group B: Benzodiazepines in Anxiety Disorders
Dr Fergus Law (Bristol) and Dr Jan Melichar (Bristol)
18:00 End of Thursday Sessions
Friday 27 January
08:45–09:15 Arrival and Coffee
09:15–10:45 The fast and the slow: exploring the duality of anxiolytic action
Professor David Nutt (London)
10:45–11:00 Refreshments
11:00–12:30 Practical therapy of anxiety: case studies
Professor David Nutt (London) and Dr David Christmas (Cambridge)
12:30–13:15 Lunch
13:15–14:30 Two Groups
Group A: Exploring Brain Mechanisms in SSRI Action
Professor David Nutt (London) and Dr David Christmas (Cambridge)
Group B: Insomnia and other Sleep Disturbances
Dr Chris Alford (Bristol) and Dr Hugh Selsick (London)
14:30–14:45 Refreshments and presenters swap rooms
14:45–16:00 Two Groups (repeated)
Group A: Exploring Brain Mechanisms in SSRI Action
Professor David Nutt (London) and Dr David Christmas (Cambridge)
Group B: Insomnia and other Sleep Disturbances
Dr Chris Alford (Bristol) and Dr Hugh Selsick (London)
16:00 End of meeting, return of feedback forms

Last edited 24th October 2017

Learning Objectives

At the end of one and a half day course, delegates will:

  • Be aware of current theories and the causes and neurochemistry of anxiety.
  • Know the pharmacology of both GABA and 5-HT acting anxiolytic drugs.
  • Have an understanding of the current clinical assessment of the various anxiety disorders.
  • Be aware of the merits and demerits of the various different classes of anxiolytic agents.
  • Understand the ongoing methodologies for investigating brain mechanisms of anxiety.
  • Know the clinical and pharmacology background of underpinning rational use of hypnotics.
  • Have an insight into the way alcohol acts on the brain and how these effects can be minimised.

Online registration facilities will NOT be available for this meeting.

Email: susan@bap.org.uk

This module is eligble for 10 CPD hours which are subject to peer group review.

Feedback from 2016 Module

"Very informative. I learnt about evidence base behind the guidelines and the rationale for not following them blindly"

"Excellent course – very informative with good handouts. Good time to ask questions and very friendly speakers"

"Excellent content and clinically relevant. The organisation was fantastic and it was a great choice of hotel"

"Excellent! Would highly recommend, thank you"

Print DOIs